KCCure talks with Dr. Michael Atkins, Deputy Director of the Georgetown-Lombardi Comprehensive Cancer Center in Washington, DC about the TIVO-3 trial and what it means for kidney cancer patients.
A search of National Cancer Institute website shows no new kidney cancer trials anywhere in the United States, same as last week. It's time to fund new research.
Even with tough cancers like kidney cancer, we can see miracles. In genetics research, we are seeing the miracle of the blueprint of cancer slowly unfolding.
Forgot your password?
No account? Sign up
Please enter your username or email address. You will receive a link to create a new password via email.
Already have an account? Login instead